Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorFernández-Juárez, Gema
dc.contributor.authorRojas-Rivera, Jorge
dc.contributor.authorvan de Logt, Anne-Els
dc.contributor.authorJustino, Joana
dc.contributor.authorSevillano, Angel
dc.contributor.authorAgraz Pamplona, Irene
dc.contributor.authorCaravaca-Fontán, Fernando
dc.date.accessioned2022-01-28T07:09:28Z
dc.date.available2022-01-28T07:09:28Z
dc.date.copyright2020
dc.date.issued2021-04
dc.identifier.citationFernández-Juárez G, Rojas-Rivera J, Logt AV, Justino J, Sevillano A, Caravaca-Fontán F, et al. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy. Kidney Int. 2021 Apr;99(4):986–98.
dc.identifier.issn1523-1755
dc.identifier.urihttps://hdl.handle.net/11351/6922
dc.descriptionCorticoides; Ciclofosfamida; Nefropatia membranosa primària
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesKidney International;99(4)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectRonyons - Malalties - Tractament
dc.subjectAvaluació de resultats (Assistència sanitària)
dc.subject.meshKidney Diseases
dc.subject.mesh/drug therapy
dc.subject.meshTreatment Outcome
dc.titleThe STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.kint.2020.10.014
dc.subject.decsenfermedades renales
dc.subject.decs/farmacoterapia
dc.subject.decsresultado del tratamiento
dc.relation.publishversionhttps://doi.org/10.1016/j.kint.2020.10.014
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Fernández-Juárez G] Nephrology Division, Hospital Universitario Fundación Alcorcón, Madrid, Spain. [Rojas-Rivera J] Nephrology Division, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain. [Logt AV] Nephrology Division, Radboud University Medical Center, Nijmegen, The Netherlands. [Justino J] Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Université Côte d’Azur, Centre National de la Recherche Scientifique (CNRS), Valbonne Sophia Antipolis, France. [Sevillano A, Caravaca-Fontán F] Nephrology Division, Instituto de Investigación Hospital Universitario 12 Octubre, Madrid, Spain. [Agraz I] Divisió de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid33166580
dc.identifier.wos000740817900004
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple